Loading...
An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation‐Negative Pancreatic Ductal Adenocarcinoma
PURPOSE. Oncogenic mutations in the KRAS gene are a well‐known driver event, occurring in >95% of pancreatic cancers. The objective of this study was to identify driver oncogene aberrations in pancreatic cancers without the KRAS mutation. METHODS. Whole‐exome and transcriptome sequencing was perf...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330701/ https://ncbi.nlm.nih.gov/pubmed/28167572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0194 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|